According to the Report, the Size of the Artificial Organs and Bionics Market in the Asia Pacific is valued at USD 4.88 Billion in 2019 and is projected to reach USD 8 Billion by 2024, increasing at a CAGR of 10.40% during the forecast period from 2019 to 2024.
Artificial organs are man-made devices that are integrated into the human body to replace the natural organs which are either partially or completely not performing its functions at all. Bionic implants are mechanical or electronic systems that function like living organisms or parts of living organisms.
The market for Artificial Organs and Bionics is mainly driven due to the increasing prevalence of acute renal failure and renal disorders due to lifestyle habits such as excessive alcohol consumption and growing geriatric population base causing a rise in organ failure rates. But, the market growth can be hampered due to continuous technological advances in artificial organ product designs which have made it difficult to redeem clear cost-effectiveness and high implantation cost of artificial organs.
Asia Pacific Artificial Organs and Bionics Market has been segmented and sub-segmented into the following categories
On the basis of region, the Artificial Organs and Bionics market in the Asia-Pacific region is projected to grow at the highest CAGR, which is greatly due to the increasing aging population and large consumer base, rising government initiatives for enhancing healthcare, and high disposable income.
Top Companies dominating the Asia Pacific Artificial Organs and Bionics Market Profiled in the Report are Orthofix International N.V., Biomet, Inc., Medtronic, Inc., Cochlear Ltd., Second Sight Medical Products, Inc., Ossur, Ekso Bionics, St. Jude Medical, Inc., Baxter International, Inc., Abiomed Inc., Asahi Kasei Medical Co., Ltd, Berlin Heart GmbH, Boston Scientific Corporation, F Hoffman-La Roche Ltd, Worldheart Corporation, Thoratec Corporation, Gambro AB, Lifenet Health, Jarvik Heart Inc.,
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Artificial Organs
5.1.2.1 Artificial Heart
5.1.2.2 Artificial Kidney
5.1.2.3 Artificial liver
5.1.2.4 Artificial pancreas
5.1.2.5 Artificial lungs
5.1.3 Bionics
5.1.3.1 Vision bionics
5.1.3.2 Ear bionics
5.1.3.3 Orthopedic bionic
5.1.3.4 Cardiac Bionics
5.1.3.5 Brain bionics
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 Technology
5.2.1 Introduction
5.2.2 Electronic bionics
5.2.3 Mechanical bionics
5.2.4 Y-o-Y Growth Analysis, By Technology
5.2.5 Market Attractiveness Analysis, By Technology
5.2.6 Market Share Analysis, By Technology
5.3 Type of fixation
5.3.1 Introduction
5.3.2 Implantable
5.3.3 Externally worn
5.3.4 Y-o-Y Growth Analysis, By Type of fixation
5.3.5 Market Attractiveness Analysis, By Type of fixation
5.3.6 Market Share Analysis, By Type of fixation
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Technology
6.1.3.4 By Type of fixation
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Technology
6.1.4.4 By Type of fixation
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Technology
6.1.5.4 By Type of fixation
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Orthofix International N.V.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Biomet, Inc.
8.3 Medtronic, Inc.
8.4 Cochlear Ltd.
8.5 Second Sight Medical Products, Inc.
8.6 Ossur
8.7 Ekso Bionics
8.8 St. Jude Medical, Inc.
8.9 Baxter International, Inc.
8.10 Abiomed Inc.
8.11 Asahi Kasei Medical Co., Ltd
8.12 Berlin Heart GmbH
8.13 Boston Scientific Corporation
8.14 F Hoffman-La Roche Ltd
8.15 Worldheart Corporation
8.16 Thoratec Corporation
8.17 Gambro AB
8.18 Lifenet Health
8.19 Jarvik Heart Inc.
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
